FOXO TECHNOLOGIES INC. Proceeds from Issuance of Private Placement
FOXO TECHNOLOGIES INC. (FOXO) reported Proceeds from Issuance of Private Placement of $2.00 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-06-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2025-04-15
- FOXO TECHNOLOGIES INC. proceeds from issuance of private placement for the quarter ending 2024-03-31 was $2.00M.
- FOXO TECHNOLOGIES INC. proceeds from issuance of private placement for the quarter ending 2023-12-31 was $431.89K.
- FOXO TECHNOLOGIES INC. proceeds from issuance of private placement for fiscal 2023 was $1.18M.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 8 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month | Proceeds from Issuance of Private Placement 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-03-31 | $2.00M 10-Q · filed 2024-06-28 | $2.43M derived: sum of 2 quarters · filed 2025-04-15 | ||||
| 2023-12-31 | $431.89K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $1.18M 10-K · filed 2025-04-15 | $1.18M 10-K · filed 2024-06-06 | |||
| 2023-09-30 | $744.00K 10-Q · filed 2024-11-19 | |||||
| 2020-12-31 | $6.33M 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |